GH · Guardant Health, Inc.
$167.88
+4.54 (+2.78%)
At close · Aug 20
Market Cap
$21.92B
Shares
134.20M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-08-12 | 2026-09-30 | |
| 8-K | 2026-07-30 | — | |
| 10-Q | 2026-07-30 | 2026-06-30 | |
| 8-K | 2026-06-18 | 2026-06-17 | |
| Investor Event Transcript | 2026-06-03 | 2026-06-30 | |
| Investor Event Transcript | 2026-06-02 | 2026-06-30 | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| 8-K | 2026-05-07 | — | |
| DEF 14A | 2026-04-28 | 2026-06-17 | |
| 8-K | 2026-04-27 | — | |
| Investor Event Transcript | 2026-03-31 | — | |
| 8-K | 2026-02-19 | — | |
| 10-K | 2026-02-19 | 2025-12-31 | |
| 8-K | 2026-01-12 | 2026-01-11 | |
| 8-K | 2025-11-07 | 2025-11-04 | |
| 10-Q | 2025-10-29 | 2025-09-30 | |
| 8-K | 2025-10-29 | — | |
| 8-K | 2025-09-24 | — | |
| 8-K | 2025-09-15 | 2025-09-12 | |
| 10-Q | 2025-07-30 | 2025-06-30 | |
| 8-K | 2025-07-30 | — | |
| 8-K | 2025-06-20 | 2025-06-18 | |
| 10-Q | 2025-04-30 | 2025-03-31 | |
| 8-K | 2025-04-30 | — | |
| DEF 14A | 2025-04-29 | 2025-06-18 | |
| 8-K | 2025-04-09 | 2025-04-03 | |
| 8-K | 2025-02-20 | — | |
| 10-K | 2025-02-20 | 2024-12-31 | |
| 8-K | 2025-02-14 | — | |
| 8-K | 2025-02-07 | 2025-02-06 | |
| 8-K | 2025-01-13 | — | |
| 10-Q | 2024-11-06 | 2024-09-30 | |
| 8-K | 2024-11-06 | — | |
| 8-K | 2024-10-24 | 2024-10-21 | |
| 8-K | 2024-08-23 | — | |
| 10-Q | 2024-08-07 | 2024-06-30 | |
| 8-K | 2024-08-07 | — | |
| 8-K | 2024-07-29 | — | |
| 8-K | 2024-07-18 | 2024-07-17 | |
| 8-K | 2024-06-14 | 2024-06-12 | |
| 8-K | 2024-05-31 | 2024-05-24 | |
| 8-K | 2024-05-24 | 2024-05-23 | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-05-09 | — | |
| DEF 14A | 2024-04-25 | 2024-06-12 | |
| 8-K | 2024-03-22 | 2024-03-18 | |
| 8-K | 2024-02-22 | — | |
| 10-K | 2024-02-22 | 2023-12-31 | |
| 8-K | 2024-02-01 | 2024-01-26 | |
| 8-K | 2024-01-08 | — |
Showing 1–50 of 124 filings
Key facts
CIK
1576280
CUSIP
40131M109
13F (30d)
567 filings
534 filers
Visit website
Investor relations